Gilead to contribute HIV treatment for 2,000 patients

Gilead, a U.S.-based biotechnology company, says that at least 2,000 single tablet regimen (STR) pills for HIV patients in Myanmar will be donated through the National AIDS Program of Myanmar.

“Myanmar faces a heavy HIV burden, and previously limited access to antiretroviral therapy means that burden is increasing. However, the quality and sophistication of healthcare professionals in Myanmar is great, and they have a strong willingness to treat patients who can immediately benefit from treatment,” Gregg H. Alton, executive vice president of corporate and medical affairs for Gilead Sciences, told Eleven Media last week.

India Sun Pharma eyes investing in Myanmar

Sun Pharma, a global pharmaceutical company headquartered in Mumbai, has discussed plans to invest in Myanmar during meetings with authorities in Nay Pyi Taw on June 25, according to the Ministry of National Planning and Economic Development.

Myanmar hospital joins hand with Singapore's Parkway

Singapore's Parkway Hospital has signed a MoU with Myanmar's Zabuthiri Specialist Hospital yesterday in Nay Pyi Taw, the official capital of Myanmar, to work together for medical services in both countries.